Regulus Therapeutics
RGLS
#6949
Rank
HK$4.39 B
Marketcap
HK$63.50
Share price
0.00%
Change (1 day)
436.85%
Change (1 year)

Regulus Therapeutics (RGLS) - Total assets

Total assets on the balance sheet as of March 2025 : HK$0.58 Billion

According to Regulus Therapeutics's latest financial reports the company's total assets are HK$0.58 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Regulus Therapeutics - Total assets on balance sheet (from 2011 to 2025)

Total assets by year

Year Total assets Change
2024-12-31HK$0.65 B172.13%
2023-12-31HK$0.24 B-34.2%
2022-12-31HK$0.36 B-31.62%
2021-12-31HK$0.53 B83.1%
2020-12-31HK$0.29 B-11.05%
2019-12-31HK$0.32 B49.86%
2018-12-31HK$0.21 B-64.03%
2017-12-31HK$0.60 B-22.12%
2016-12-31HK$0.78 B-28.62%
2015-12-31HK$1.09 B-17.79%
2014-12-31HK$1.33 B39.38%
2013-12-31HK$0.95 B18.93%
2012-12-31HK$0.80 B140.92%
2011-12-31HK$0.33 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
GlaxoSmithKline
GSK
HK$641.68 B 110,102.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sanofi
SNY
HK$1.185 T 203,470.95%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
HK$227.28 B 38,933.89%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
HK$890.67 B 152,862.87%๐Ÿ‡ฌ๐Ÿ‡ง UK
Alnylam Pharmaceuticals
ALNY
HK$37.75 B 6,383.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
HK$0.68 B 18.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$753.96 B 129,385.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA